Baicalein stimulates osteoblast differentiation via coordinating activation of MAP kinases and transcription factors

Journal of Cellular Biochemistry

Volumn 104, Issue 5, 2008, Pages 1906-1917

  Kim, Jin Mi ^a,b   Lee, Su Ui ^a,c   Kim, Young Sup ^a   Min, Yong Ki ^a   Kim, Seong Hwan ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Yonsei University College of Dentistry   (South Korea)

^c Chungnam National University   (South Korea)

Author keywords

AP 1; Baicalein; MAP kinases; NF B; NFATc1; Osteoblast differentiation

Indexed keywords

BAICALEIN; CALCIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ARTICLE; CELL CLONE; CELL DIFFERENTIATION; CELL STRAIN; ENZYME ACTIVATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; ENZYME ACTIVATION; FLAVANONES; GENE EXPRESSION REGULATION; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; OSTEOBLASTS; PROTEIN TRANSPORT; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 50249098598     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21760     Document Type: Article

References (48)

1. Baron R. 2003. General principles of bone biology. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism, 5th edition. Washington, DC: American Society for Bone and Mineral Research, pp 1-8.
2. Boise LH, Petryniak B, Mao X, June CH, Wang CY, Lindsten T, Bravo R, Kovary K, Leiden JM, Thompson CB. 1993. The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and Jun. Mol Cell Biol 13:1911-1919.
3. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
4. Chae HJ, Jeong BJ, Ha MS, Lee JK, Byun JO, Jung WY, Yun YG, Lee DG, Oh SH, Chae SW, Kwak YG, Kim HHm Lee ZH, Kim HR. 2002. ERK MAP kinase is required in 1,25(OH)2D3-induced differentiation in human osteoblasts. Immunopharmacol Immunotoxicol 24:31-41.
5. Chen YC, Chow JM, Lin CW, Wu CY, Shen SC. 2006. Baicalein inhibition of oxidative-stress-induced apoptosis via modulation of ERKs activation and induction of HO-1 gene expression in rat glioma cells C. Toxicol Appl Pharmacol 216:263-273.
6. Chen CJ, Raung SL, Liao SL, Chen SY. 2004. Inhibition of inducible nitric oxide synthase expression by baicalein in endotoxin/cytokine-stimulated microglia. Biochem Pharmacol 5:957-965.
7. Choi EM. 2007. Modulatory effects of luteolin on osteoblastic function and inflammatory mediators in osteoblastic MC3T3-E1 cells. Cell Biol Int 31:870-877.
8. Eferl R, Hoebertz A, Schilling AF, Rath M, Karreth F, Kenner L, Amling M, Wagner EF. 2004. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J 23:2789-2799.
9. Farzaneh-Far A, Davies JD, Braam LA, Spronk HM, Proudfoot D, Chan SW, O'Shaughnessy KM, Weissberg PL, Vermeer C, Shanahan CM. 2001. A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. J Biol Chem 276:32466-32473.
10. Franzoso G, Carlson L, Brown K, Daucher MB, Bressler P, Siebenlist U. 1996. Activation of the serum response factor by p65/NF-κ. EMBO J 15:3403-3412.
11. Fujioka S, Niu J, Schmidt C, Sclabas GM, Peng B, Uwagawa T, Li Z, Evans DB, Abbruzzese JL, Chiao PJ. 2004. NF-κB and AP-1 connection: Mechanism of NF-κB-dependent regulation of AP-1 activity. Mol Cell Biol 24: 7806-7819.
12. Garces C, Garcia LE. 2006. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis. Maturitas 54:47-54.
13. Gerstenfeld LC, Uporova T, Ashkar S, Salih E, Gotoh Y, McKee MD, Nanci A, Glimcher MJ. 1995. Regulation of avian osteopontin pre- and posttranscriptional expression in skeletal tissues. Ann NY Acad Sci 760: 67-82.
14. Harada S, Rodan GA. 2003. Control of osteoblast function and regulation of bone mass. Nature 423:349-355.
15. Hipskind RA, Bilbe G. 1998. MAP kinase signaling cascades and gene expression in osteoblasts. Front Biosci 3:d804-d816.
16. Hong T, Jin GB, Cho S, Cyong JC. 2002. Evaluation of the anti-inflammatory effect of baicalein on dextran sulfate sodium-induced colitis in mice. Planta Med 68:268-271.
17. Hwang JM, Tseng TH, Tsai YY, Lee HJ, Chou FP, Wang CJ, Chu CY. 2005. Protective effects of baicalein on tert-buty1 hydroperoixde-induced hepatic toxicity in rat hepatocytes. J Biomed Sci 12:389-397.
18. Jochum W, David JP, Elliott C, Wutz A, Plenk H, Jr., Matsuo K, Wagner EF. 2000. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med 6:980-984.
19. Kim HJ, Lee MH, Kim HJ, Shin HI, Choi JY, Ryoo HM. 2002. Okadaic acid stimulates osteopontin expression through de novo induction of AP-1. J Cell Biochem 87:93-102.
20. Kimata M, Shichijo M, Miura T, Serizawa I, Inagaki N, Nagai H. 2000. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy 30:501-508.
21. Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, Nakashima K, Takayanagi H. 2005. NFAT and Osterix cooperatively regulate bone formation. Nat Med 11:880-885.
22. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL. 2001. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276:14443-14450.
23. Lampasso JD, Chen W, Marzec N. 2006. The expression profile of PKC isoforms during MC3T3-E1 differentiation. Int J Mol Med 17:1125-1131.
24. Lee BH, Lee SJ, Kang TH, Kim DH, Sohn DH, Ko G, Kim YC. 2000. Baicalein, an in vitro antigenotoxic compound from Scutellaria baicalensis. Planta Med 66:70-71.
25. -δδCT method. Methods 25:402-408.
26. McCabe LR, Banerjee C, Kundu R, Harrison RJ, Dobner PR, Stein JL, Lian JB, Stein GS. 1996. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: Role of Fra-2 and Jun D during differentiation. Endocrinology 137:4398-4408.
27. McCabe LR, Kockx M, Lian J, Stein J, Stein G. 1995. Selective expression of fos- and jun-related genes during osteoblast proliferation and differentiation. Exp Cell Res 218:255-262.
28. Moses S, Franzen A, Lovdahl C, Hultgardh-Nilsson A. 2001. Injury-induced osteopontin gene expression in rat arterial smooth muscle cells is dependent on mitogen-activated protein kinases ERK1/ERK. Arch Biochem Biophys 396:133-137.
29. Nakahata N, Tsuchiya C, Nakatani K, Ohizumi Y, Ohkubo S. 2003. Baicalein inhibits Raf-1-mediated phosphorylation of MEK-1 in C6 rat glioma cells. Eur J Pharmacol 461:1-7.
30. Narayanan K, Srinivas R, Peterson MC, Ramachandran A, Hao J, Thimmapaya B, Scherer PE, George A. 2004. Transcriptional regulation of dentin matrix protein 1 by JunB and p300 during osteoblast differentiation. J Biol Chem 279:44294-44302.
31. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. 2001. Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795.
32. Ono K, Nakane H. 1990. Mechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids. J Biochem 108:609-613.
33. Putnam SE, Scutt AM, Bicknell K, Priestley CM, Williamson EM. 2007. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother Res 21:99-112.
34. Renault MA, Jalvy S, Potier M, Belloc I, Genot E, Dekker LV, Desgranges C, Gadeau AP. 2005. UTP induces osteopontin expression through a coordinate action of NF-κB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells. J Biol Chem 280: 2708-2713.
35. Rodan GA, Martin TJ. 2000. Therapeutic approaches to bone diseases. Science 289:1508-1514.
36. Rosen CJ, Bilezikian JP. 2001. Clinical review 123: Anabolic therapy for osteoporosis. J Clin Endocrinol Metab 86:957-964.
37. Rozen S, Skaletsky HJ. 2000. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, editors. Bioinformatics methods and protocols: Methods in molecular biology. Totowa: Humana Press. pp 365-386.
38. Sakata R, Minami S, Sowa Y, Yoshida M, Tamaki T. 2004. Trichostatin A activates the osteopontin gene promoter through AP1 site. Biochem Biophys Res Commun 315: 959-963.
39. Shao ZH, Hoek TL, Qin Y, Becker LB, Schumacker PT, Li CQ, Dey L, Barth E, Halpern H, Rosen GM, Yuan CS. 2002. Baicalein attenuates oxidant stress in cardiomyocytes. Am J Physiol 282:H999-H1006.
40. Stein GS, Lian JB, Stein JL, van Wijnen AJ, Montecino M. 1996. Transcriptional control of osteoblast growth and differentiation. Physiol Rev 76:593-629.
41. Suzuki A, Guicheux J, Palmer G, Miura Y, Oiso Y, Bonjour JP, Caverzasio J. 2002. Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone 30:91-98.
42. Vaananen K. 2005. Mechanism of osteoclast mediated bone resorption-rationale for the design of new therapeutics. Adv Drug Deliv Rev 57:959-971.
43. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. 1995. Rel/NF-κB/IκB family: Intimate tales of association and dissociation. Genes Dev 9:2723-2735.
44. Wagner EF. 2002. Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis 61(Suppl 2):ii40-ii42.
45. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT. 1999. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14:893-903.
46. Whelan AM, Jurgens TM, Bowles SK. 2006. Natural health products in the prevention and treatment of osteoporosis: Systematic review of randomized controlled trials. Ann Pharmacother 40:836-849.
47. Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, Crabtree GR. 2006. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell 10:771-782.
48. Wu CC, Li YS, Haga JH, Wang N, Lian IY, Su FC, Usami S, Chien S. 2006. Roles of MAP kinase in the regulation of bone matrix gene expressions in human osteoblasts by oscillatory fluid flow. J Cell Biochem 98:632-641.